Resultados de la búsqueda 161-170 of 9333 for Stretch+marks

  1. Cirugía - Ensayos clínicos - Mayo Clinic

    The purpose of this study, as a proof-of-concept, is to investigate whether ex vivo fluorescence microscopy can provide adequate visualization of cutaneous ...

  2. Dermatología - Ensayos clínicos - Mayo Clinic

    To leverage deep learning models for classification, detection, and localization of tumor for extramammary Paget's disease on ex-vivo confocal microscopy images ...

  3. Cirugía - Ensayos clínicos - Mayo Clinic

    Almost one-half million people suffer venous thromboembolism annually in the United States, and one-third die from this disease.

  4. Cirugía - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to collect adipose tissue from patients undergoing elective surgery, or from healthy volunteers, test the donors to assure that ...

  5. Cirugía - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this study is to assess the differences in microvascular anastomosis outcomes between the experiment aneurysmal subarachnoid ...

  6. Cirugía - Ensayos clínicos - Mayo Clinic

    Almost one-half million people suffer venous thromboembolism annually in the United States, and one-third die from this disease. Massive bleeding from injury ...

  7. Cirugía - Ensayos clínicos - Mayo Clinic

    Rochester, Minn., Jacksonville, Fla. To collect post-approval data comparing the safety and effectiveness of CraniSeal Dural Sealant to DuraSeal Dural Sealant.

  8. Cirugía - Ensayos clínicos - Mayo Clinic

    Almost one-half million people suffer venous thromboembolism annually in the United States, and one-third die from this disease.

  9. Cirugía - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate different techniques to repair internal iliac artery aneurysms. Report short and long term clinical outcomes with ...

  10. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    placebo in combination with ado-trastuzumab emtansine (TTT-DM1) in patients with stage II-III HER2+ breast cancer with residual disease post-neoadjuvant ...